The FWO supports fundamental and strategic research
Science opens new horizons
Science pushes the boundaries of our knowledge. The Research Foundation – Flanders (FWO) is the agency that supports ground-breaking fundamental and strategic research at the universities of the Flemish Community. The FWO also stimulates cooperation between the Flemish universities and other research institutes.
Science creates opportunities
Fundamental scientific research is focussed on expanding knowledge about human beings and their environment. As the level of knowledge of our society grows, so does the quality of life in general and the quality of training in particular. Young people are thus provided with every opportunity to deploy their talents in a broad array of disciplines.
Research financed by FWO, specially Strategic Basic Research, also contains an important step in the valorisation of scientific breakthroughs.
Science is essential for our well-being
In the long term, such a high level of knowledge in combination with the resulting human capital pave the way for targeted and applied research, which has also a policy-supporting role. Decisions in economic or social domains can then also be influenced by the work of excellent research groups. This is not surprising, as ground-breaking research may lie at the heart of solutions to the key challenges facing our society today (environment, mobility, health, etc.). Science is the driver of innovation.
Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need. Acer’s late-stage clinical pipeline includes two candidates for severe genetic disorders: EDSIVO™ (celiprolol) for vascular Ehlers-Danlos syndrome (vEDS), and ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for urea cycle disorders (UCD) and Maple Syrup Urine Disease (MSUD). There are no FDA-approved drugs for vEDS and MSUD and limited options for UCD, which collectively impact approximately 7,000 patients in the U.S. Acer’s product candidates have clinical proof-of-concept and mechanistic differentiation, and Acer intends to seek approval for them in the U.S. by using the regulatory pathway established under section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (FFDCA) that allows an applicant to rely at least in part on third-party data for approval, which may expedite the preparation, submission, and approval of a marketing application.
For 90 years, the Fund for Scientific Research – FNRS has been contributing to the development of basic research in the Wallonia-Brussels Federation through its policy of encouraging scientific excellence and supporting researchers.
With its new PHARE II strategic refinancing plan, the FRS-FNRS wishes to meet the challenges related to the evolution of research policies at the international level and to help researchers from the Wallonia-Brussels Federation to fit into the European Research Area. This plan is part of a very favorable national and international context for research. The European Horizon 2020 program thus demonstrates an understanding of the essential role of research as a driver of new knowledge production and a primary link in the innovation process.
It is part of a national and international context very favorable to research, but also in a dynamics of evolution of the FRS-FNRS, which has the will to evolve its structures and to develop its strategic projects at the service of researchers and research, building on its values of Creativity, Excellence, and Transparency.
We Design manufactures braces with minimal material use without compromising the comfort and durability of the splint. At We Design people work with passion and commitment. Every day expertise, skills and dedication meet each other to create custom- made splints for our customers.
We Design was established in 1999 and is founded by Wouter Robin Engelshoven. We Design has blossomed to be a household name within the orthopaedic field. We are specialised in the manufacturing of silver splints for finger, thumb, hand, wrist, andn elbow. In the Netherlands and abroad, the splints have proved themselves to be effective and comfortable to wear in relation to the problem addressed.
Basko Healthcare is a company with more than 80 years of experience in orthopedic devices. We specialize in the development, production and sales of orthopedic technical aids and stoma care belts. With our innovative products we mainly supply the medical specialist, orthopedic workshops, healthcare institutions and pharmacies in the Benelux, Germany, Austria, Switzerland, other Western European countries, the United States, Japan and Australia and many more.
The BeSHG was launched in March 2000. The aim of the Society is to allow all scientists involved in the field of human genetics, working in all Belgian universities, and all independent research institutes or genetic centers in Belgium to have an official representative Society in Belgium. The BeSHG is aimed at promoting Human Genetics in its wider sense, a.o. by supporting genetic research, improving exchanges between Belgium and foreign countries, organising scientific meetings, and enhancing collaboration between Belgian labs. The BeSHG will represent the community of Belgian geneticists towards the other national and international Societies of Genetics, and is intended to become a discussion forum on scientific, professional, social and ethical issues linked to the practice of human genetics.
DM Orthotics is a world leading creator of medical rehabilitation and sports performance products.
We provide elastomeric fabric, dynamic movement orthoses to over 25 countries, helping to improve the lives of people who face a range of physical challenges. We are dedicated to the research, development and evolution of our products, with the aim to constantly improve the lives of the people who use them.
Recognising the clinical importance of Dynamic Elastomeric Fabric Orthoses (DEFOs) for the future, Martin Matthews’ entrepreneurial spirit saw him set up a new manufacturing site for the pioneering orthoses, securing the jobs and expertise of the existing production staff at Tyco (Redruth) UK. With a small but dedicated team of 15 staff, he rebranded his DEFOs, ‘Dynamic Movement Orthoses’ (DMO) and in November 2004, DM Orthotics was born. We now employ over 55 people nationwide, from clinicians to pattern designers.